Targeted imaging offers advantages over physiological imaging for evaluation of angiogenic therapy.
Albert J
AJ
Sinusas
D000818:Animals; D002196:Capillaries / Q000000981:diagnostic imaging / Q000503:physiopathology; D017023:Coronary Angiography; D003326:Coronary Circulation; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D004452:Echocardiography; D005355:Fibrosis; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005960:Glucosides / Q000378:metabolism; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism / Q000473:pathology*; D018919:Neovascularization, Physiologic; D009842:Oligopeptides / Q000378:metabolism; D019275:Radiopharmaceuticals / Q000378:metabolism; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis* / Q000235:genetics
D005960:Glucosides; D039302:Integrin alphaVbeta3; D009842:Oligopeptides; D019275:Radiopharmaceuticals; D042461:Vascular Endothelial Growth Factor A; C498055:iodogluco-RGD